| Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers KJ Olbrich, D Müller, S Schumacher, E Beck, K Meszaros, F Koerber Infectious diseases and therapy 7, 421-438, 2018 | 177 | 2018 |
| A Data-Driven Simulation of HIV Spread Among Young Men Who Have Sex With Men: Role of Age and Race Mixing and STIs EC Beck, M Birkett, B Armbruster, B Mustanski JAIDS Journal of Acquired Immune Deficiency Syndromes 70 (2), 186-194, 2015 | 69 | 2015 |
| Cost-effectiveness of 4CMenB infant vaccination in England: a comprehensive valuation considering the broad impact of serogroup B invasive meningococcal disease E Beck, J Klint, M Neine, S Garcia, K Meszaros Value in Health 24 (1), 91-104, 2021 | 37 | 2021 |
| Elementary proof of convergence to the mean-field model for the SIR process B Armbruster, E Beck Journal of mathematical biology 75, 327-339, 2017 | 31 | 2017 |
| Systematic Literature Review and Quantitative Analysis of Health Problems Associated with Sexually Transmitted Neisseria gonorrhoeae Infection J Whelan, J Eeuwijk, E Bunge, E Beck Infectious Diseases and Therapy 10, 1887-1905, 2021 | 27 | 2021 |
| Risk factors for cervical cancer in women in China: A meta-model S Aballéa, E Beck, X Cheng, N Demarteau, X Li, F Ma, M Neine, FH Zhao Women's Health 16, 1745506520940875, 2020 | 25 | 2020 |
| The potential public health impact of adolescent 4CMenB vaccination on Neisseria gonorrhoeae infection in England: a modelling study KJ Looker, R Booton, N Begum, E Beck, J Shen, KME Turner, ... BMC Public Health 23 (1), 1, 2023 | 23 | 2023 |
| Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework E Beck, E Biundo, N Devlin, TM Doherty, AJ Garcia-Ruiz, M Postma, ... Vaccine 40 (30), 4008-4016, 2022 | 23 | 2022 |
| Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts M Postma, E Biundo, A Chicoye, N Devlin, TM Doherty, AJ Garcia-Ruiz, ... Vaccine 40 (30), 3999-4007, 2022 | 22 | 2022 |
| Vaccine market access pathways in the EU27 and the United Kingdom− analysis and recommendations for improvements V Laigle, MJ Postma, M Pavlovic, C Cadeddu, E Beck, A Kapusniak, ... Vaccine 39 (39), 5706-5718, 2021 | 22 | 2021 |
| An elementary proof of convergence to the mean-field equations for an epidemic model B Armbruster, E Beck IMA Journal of Applied Mathematics 82 (1), 152-157, 2017 | 22 | 2017 |
| Healthcare resource consumption and cost of invasive meningococcal disease in France: a study of the National Health Insurance Database C Weil-Olivier, MK Taha, C Emery, S Bouée, E Beck, E Aris, ... Infectious diseases and therapy 10 (3), 1607-1623, 2021 | 20 | 2021 |
| Long-term mortality and state financial support in invasive meningococcal disease—real-world data analysis using the French national claims database (SNIIRAM) J Shen, S Bouée, E Aris, C Emery, EC Beck Infectious Diseases and Therapy, 1-13, 2022 | 19 | 2022 |
| Resource management and process change in a simplified model of the emergency department E Beck, H Balasubramanian, PL Henneman Proceedings of the 2009 Winter Simulation Conference (WSC), 1887-1895, 2009 | 19 | 2009 |
| Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to England E Beck, J Klint, S Garcia, V Abbing, V Abitbol, O Akerborg, L Argante, ... Vaccine 38 (47), 7558-7568, 2020 | 18 | 2020 |
| The potential clinical impact and cost-effectiveness of the updated COVID-19 mRNA Fall 2023 vaccines in the United States MA Kohli, M Maschio, K Joshi, A Lee, K Fust, E Beck, N Van de Velde, ... Journal of Medical Economics 26 (1), 1532-1545, 2023 | 16 | 2023 |
| Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database C Weil-Olivier, MK Taha, S Bouée, C Emery, V Loncle-Provot, ... Human vaccines & immunotherapeutics 18 (1), 2021764, 2022 | 14 | 2022 |
| Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease S Scholz, M Schwarz, E Beck, K Meszaros, M Schneider, B Ultsch, ... Infectious Diseases and Therapy, 1-21, 2022 | 13 | 2022 |
| Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework S Kavikondala, K Haeussler, X Wang, MT Bausch-Jurken, M Nassim, ... Infectious Diseases and Therapy 13 (4), 779-811, 2024 | 10 | 2024 |
| Comparative Effectiveness of the Bivalent (Original/Omicron BA. 4/BA. 5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults With Underlying Medical Conditions … H Kopel, VH Nguyen, A Bogdanov, I Winer, C Boileau, T Ducruet, N Zeng, ... Vaccines 12 (10), 1107, 2024 | 7 | 2024 |
Michelle BirkettAssociate Professor, Northwestern UniversityE-mailová adresa ověřena na: northwestern.edu